Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Change In Inventory : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Zhejiang East-Asia Pharmaceutical Co Change In Inventory?

Zhejiang East-Asia Pharmaceutical Co's change in inventory for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Zhejiang East-Asia Pharmaceutical Co's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Zhejiang East-Asia Pharmaceutical Co's change in inventory for the fiscal year that ended in Dec. 2024 was ¥-241 Mil. It means Zhejiang East-Asia Pharmaceutical Co's inventory increased by ¥241 Mil from Dec. 2023 to Dec. 2024 .

Zhejiang East-Asia Pharmaceutical Co's Total Inventories for the quarter that ended in Mar. 2025 was ¥773 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Zhejiang East-Asia Pharmaceutical Co's Days Inventory for the quarter that ended in Mar. 2025 was 552.22.

Inventory Turnover measures how fast the company turns over its inventory within a year. Zhejiang East-Asia Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.17.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zhejiang East-Asia Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 3.91.

Zhejiang East-Asia Pharmaceutical Co Change In Inventory Historical Data

The historical data trend for Zhejiang East-Asia Pharmaceutical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang East-Asia Pharmaceutical Co Change In Inventory Chart

Zhejiang East-Asia Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

19.82

-158.47

-63.04

-148.97

-240.69

Zhejiang East-Asia Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Zhejiang East-Asia Pharmaceutical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zhejiang East-Asia Pharmaceutical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	746.7495	/	123.394	*	365 / 4
	=	552.22

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zhejiang East-Asia Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	123.394	/	746.7495
	=	0.17

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zhejiang East-Asia Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	746.7495	/	190.921
	=	3.91

Zhejiang East-Asia Pharmaceutical Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Zhejiang East-Asia Pharmaceutical Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang East-Asia Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang East-Asia Pharmaceutical Co Ltd (SHSE:605177) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 118, Laodong North Road, 23rd Floor, Chamber of Commerce Building, Huangyan District, Zhejiang Province, Taizhou, CHN

Website

http://www.eapharm.cn

Zhejiang East-Asia Pharmaceutical Co Ltd is mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules. The company's main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, piperazine, ticlazole and so on.

Zhejiang East-Asia Pharmaceutical Co Headlines

No Headlines